ARTICLE | Clinical News
Relebactam regulatory update
September 15, 2014 7:00 AM UTC
Merck said FDA granted Fast Track and Qualified Infectious Disease Product (QIDP) designations to relebactam to treat complicated urinary tract infections (cUTIs), complicated intra-abdominal infectio...